A conversation with Noelle Walsh, corporate vice president of supply chain with The Dow Chemical Co.

In 2011, batches of a cancer medication called Avastin, on their way to U.S. doctors from Canada, were found to contain no active ingredients. They were counterfeit - a rarity on U.S. soil. While no patient ever received the drugs, the fact that a potentially life-threatening counterfeit was able to make it to the U.S. shocked the pharmaceutical industry. It pointed to a growing trend - triggered by the rise of e-commerce and globalization - reaching the United States.

Most senior tax executives see significant international tax changes over the next two years spurred by the Organisation for Economic Co-operation and Development's base erosion and profit shifting (BEPS) project, according to a survey released by EY at its 34th Annual International Tax Conference.

Negotiations over the Trans-Pacific Partnership have at long last come to a successful end. But ratification of the agreement is far from assured - and some key questions remain to be answered.

The state of readiness in the chemical industry for the Globally Harmonized System of Classification (GHS) and OSHA's Hazard Communication Standard (HCS) is less than ideal, according to a survey from Loftware, provider of barcode labeling solutions.